The reverse transcription inhibitor abacavir shows anticancer activity in prostate cancer cell lines.
Carlini F, Ridolfi B, Molinari A, Parisi C, Bozzuto G, Toccacieli L, Formisano G, De Orsi D, Paradisi S, Grober OM, Ravo M, Weisz A, Arcieri R, Vella S, Gaudi S.
Carlini F, et al. Among authors: de orsi d.
PLoS One. 2010 Dec 3;5(12):e14221. doi: 10.1371/journal.pone.0014221.
PLoS One. 2010.
PMID: 21151977
Free PMC article.